Gene · 6895
TARBP2: TARBP2 subunit of RISC loading complex
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TARBP2: TARBP2 subunit of RISC loading complex. Genes, record 6895. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6895
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15633 | RISC-loading complex subunit TARBP2 | 366 | 10 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 66449 | Q15633 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2179 | Q15633 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2179 | Q15633 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4959 | Q15633 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 86723 | Q15633 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 189694 | Q15633 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 11309 | Q15633 | Espacenet |
| US 10925935 B2 | 2021-02-23 | 4959 | Q15633 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 246884 | Q15633 | Espacenet |
| US 10155029 B2 | 2018-12-18 | 4959 | Q15633 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants898
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TARBP2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 4 | 2025 |
| P50CA127001 | SPORE in Brain Cancer | 4 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 3 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA093373 | Cancer Center Support Grant P30 | 2 | 2025 |
1 to 10 of 898Source NIH's project files
See all 898 nih grantsPapers1,452
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of MYH6, MYH7, and MYH7B expression and their associated microRNAs in human end-stage heart failure. | Front Cardiovasc Med | 2026 | 42630156 | PubTator, text mining | PubMed |
| Steroid-Resistant Idiopathic Nephrotic Syndrome Reveals a Distinct Maladaptive Molecular State. | Kidney Int Rep | 2026 | 42375703 | PubTator, text mining | PubMed |
Revealing the function and mechanism of piRNA-related genes in bladder cancer through single-cell sequencing and methylation analyses and construction of prognostic features based on consensus clustering. | Curr Urol | 2026 | 41668898 | PubTator, text mining | PubMed |
| Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery. | Nucleic Acids Res | 2026 | 41569158 | PubTator, text mining | PubMed |
| The Potential of Noncoding RNAs-siRNAs in Cancer Research and Therapy: Challenges and Solutions. | Exp Suppl | 2026 | 41479113 | PubTator, text mining | PubMed |
| Disrupted miRNA Biogenesis Machinery Reveals Common Molecular Pathways and Diagnostic Potential in MDS and AML. | Biomedicines | 2025 | 41463093 | PubTator, text mining | PubMed |
| A 3,4-diamino-substituted coumarin derivative as a TRBP inhibitor suppresses tumor growth in breast cancer by inducing cellular senescence. | Am J Cancer Res | 2025 | 41244116 | PubTator, text mining | PubMed |
| Targeting RNA-binding proteins with small molecules: perspectives and challenges. | Front Chem | 2025 | 41112581 | PubTator, text mining | PubMed |
| Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | 40826140 | PubTator, text mining | PubMed |
| TRBP modulates RLR signaling by inhibiting PKR-mediated antiviral stress granule formation. | Sci Rep | 2025 | 40593223 | PubTator, text mining | PubMed |
1 to 10 of 1,452
See all 1,452 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6895
GET https://conductscience.org/api/genes/v1/6895/patents?page=2